Innovation Pharmaceuticals Inc (IPIX)

[sunspotter]

"Statistically, most will be fine and recover on their own without Molunpriavir or much help from hospitals."

Categorically false.

In the study, first of all:

"Merck and Ridgeback’s Investigational Oral Antiviral molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent Compared to Placebo for Patients with Mild or Moderate COVID-19 in Positive Interim Analysis of Phase 3 Study"

Hospitalisation is not just inconvenient, it's dangerous and expensive. Very expensive.

And secondly:

"no deaths were reported in patients who received molnupiravir, as compared to 8 deaths in patients who received placebo"

You might think avoiding eight deaths is insignificant, but I promise you neither the subjects who survived because of molnupiravir nor their loved ones think it doesn't matter.

If the brilacidin study has eight fewer deaths than the comparison arm, I think IPIX supporters would sing a different tune, especially if tere were no deaths at all in the brilacidin arm.

But I can guarantee you it won't. It's simply not powered enough.

https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat/